NUR-641E FINAL EXAM PREP | ALL POSSIBLE
QUESTIONS AND ANSWERS | 2026 UPDATE |
WITH COMPLETE SOLUTIONS - GCU.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A nurse educator is teaching about the four phases of pharmacokinetics. What is
the correct order of these phases?
A) Distribution, Absorption, Metabolism, Excretion
B) Absorption, Distribution, Metabolism, Excretion
C) Metabolism, Absorption, Distribution, Excretion
D) Absorption, Metabolism, Distribution, Excretion
Answer: B
Rationale: Pharmacokinetics involves four phases: absorption from the
administration site into the bloodstream, distribution from the bloodstream into
interstitial and intracellular fluid, metabolism (biotransformation) via hepatic
metabolism or other tissues, and excretion (elimination) of the drug and its
metabolites from the body .
Question 2
A patient has been taking a medication with a half-life of 12 hours. The nurse
practitioner explains that a steady state concentration will be reached in
approximately:
A) 24-36 hours
B) 48-60 hours
,C) 72-84 hours
D) 96-108 hours
Answer: B
Rationale: Steady state is typically achieved within 4-5 half-lives of the drug. For a
drug with a 12-hour half-life, steady state would be reached in approximately 48-
60 hours (4-5 × 12 hours). This is the time required for the rate of drug
administration to equal the rate of drug elimination .
Question 3
A drug that exhibits zero-order (nonlinear) pharmacokinetics:
A) Is metabolized proportionally to its concentration
B) Is metabolized at a constant rate per unit of time
C) Reaches steady state in 2 half-lives
D) Is eliminated more rapidly at higher concentrations
Answer: B
Rationale: Zero-order kinetics means the drug is metabolized at a constant rate
per unit of time regardless of concentration. In contrast, first-order kinetics means
metabolism is directly proportional to the free concentration of the drug .
Question 4
Which of the following best describes the drug development process phase that
involves clinical research in humans comparing the new drug to accepted
medications or placebo for efficacy and safety?
A) Phase I
B) Phase II
C) Phase III
D) Phase IV
,Answer: C
Rationale: Phase III clinical research involves comparing the new drug to accepted
medications or placebo for efficacy and safety in a larger patient population.
Phase I begins with animal testing and healthy human subjects; Phase II focuses
primarily on medication safety; Phase IV involves post-market studies to determine
additional side effects not seen during lab testing .
Question 5
A patient taking a CYP3A4 substrate medication is instructed to avoid grapefruit
juice because it may:
A) Decrease drug metabolism, leading to subtherapeutic levels
B) Increase drug levels, leading to adverse effects
C) Have no effect on the medication
D) Increase renal excretion of the drug
Answer: B
Rationale: Grapefruit juice inhibits CYP3A4 enzymes, which can decrease
metabolism of CYP3A4 substrate drugs and increase their serum levels, potentially
leading to adverse effects. CYP3A4 metabolizes approximately 50% of drugs,
making this interaction clinically significant .
Question 6
A medication error reporting should include which of the following components?
A) Only the name of the medication involved
B) The medication, dose, route, time, patient response, and contributing factors
C) Only the patient's identifying information
D) The name of the provider who prescribed the medication
Answer: B
, Rationale: Comprehensive medication error reporting should include the
medication name, dose, route, time of administration, patient response, and
contributing factors. Several organizations address medication safety, including
the Institute for Safe Medication Practices (ISMP), Institute of Medicine (IOM), and
the FDA's Safe Use Initiative .
Question 7
A drug is 90% plasma protein bound. A patient with hypoalbuminemia is
prescribed this drug. Which of the following is most likely to occur?
A) Decreased free drug concentration
B) Increased free drug concentration and risk of toxicity
C) No change in drug effect
D) Decreased drug half-life
Answer: B
Rationale: In hypoalbuminemia, there are fewer protein binding sites available.
This results in a higher free (unbound) drug concentration, which can increase
pharmacological effects and risk of toxicity. This is particularly important for drugs
that are highly protein bound, such as phenytoin .
Question 8
Which of the following is classified as a Phase I reaction in drug metabolism?
A) Glucuronidation
B) Oxidation via CYP450 enzymes
C) Acetylation
D) Sulfation
Answer: B
Rationale: Phase I reactions (functionalization reactions) include oxidation,
reduction, and hydrolysis, typically mediated by cytochrome P450 enzymes. Phase
QUESTIONS AND ANSWERS | 2026 UPDATE |
WITH COMPLETE SOLUTIONS - GCU.
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A nurse educator is teaching about the four phases of pharmacokinetics. What is
the correct order of these phases?
A) Distribution, Absorption, Metabolism, Excretion
B) Absorption, Distribution, Metabolism, Excretion
C) Metabolism, Absorption, Distribution, Excretion
D) Absorption, Metabolism, Distribution, Excretion
Answer: B
Rationale: Pharmacokinetics involves four phases: absorption from the
administration site into the bloodstream, distribution from the bloodstream into
interstitial and intracellular fluid, metabolism (biotransformation) via hepatic
metabolism or other tissues, and excretion (elimination) of the drug and its
metabolites from the body .
Question 2
A patient has been taking a medication with a half-life of 12 hours. The nurse
practitioner explains that a steady state concentration will be reached in
approximately:
A) 24-36 hours
B) 48-60 hours
,C) 72-84 hours
D) 96-108 hours
Answer: B
Rationale: Steady state is typically achieved within 4-5 half-lives of the drug. For a
drug with a 12-hour half-life, steady state would be reached in approximately 48-
60 hours (4-5 × 12 hours). This is the time required for the rate of drug
administration to equal the rate of drug elimination .
Question 3
A drug that exhibits zero-order (nonlinear) pharmacokinetics:
A) Is metabolized proportionally to its concentration
B) Is metabolized at a constant rate per unit of time
C) Reaches steady state in 2 half-lives
D) Is eliminated more rapidly at higher concentrations
Answer: B
Rationale: Zero-order kinetics means the drug is metabolized at a constant rate
per unit of time regardless of concentration. In contrast, first-order kinetics means
metabolism is directly proportional to the free concentration of the drug .
Question 4
Which of the following best describes the drug development process phase that
involves clinical research in humans comparing the new drug to accepted
medications or placebo for efficacy and safety?
A) Phase I
B) Phase II
C) Phase III
D) Phase IV
,Answer: C
Rationale: Phase III clinical research involves comparing the new drug to accepted
medications or placebo for efficacy and safety in a larger patient population.
Phase I begins with animal testing and healthy human subjects; Phase II focuses
primarily on medication safety; Phase IV involves post-market studies to determine
additional side effects not seen during lab testing .
Question 5
A patient taking a CYP3A4 substrate medication is instructed to avoid grapefruit
juice because it may:
A) Decrease drug metabolism, leading to subtherapeutic levels
B) Increase drug levels, leading to adverse effects
C) Have no effect on the medication
D) Increase renal excretion of the drug
Answer: B
Rationale: Grapefruit juice inhibits CYP3A4 enzymes, which can decrease
metabolism of CYP3A4 substrate drugs and increase their serum levels, potentially
leading to adverse effects. CYP3A4 metabolizes approximately 50% of drugs,
making this interaction clinically significant .
Question 6
A medication error reporting should include which of the following components?
A) Only the name of the medication involved
B) The medication, dose, route, time, patient response, and contributing factors
C) Only the patient's identifying information
D) The name of the provider who prescribed the medication
Answer: B
, Rationale: Comprehensive medication error reporting should include the
medication name, dose, route, time of administration, patient response, and
contributing factors. Several organizations address medication safety, including
the Institute for Safe Medication Practices (ISMP), Institute of Medicine (IOM), and
the FDA's Safe Use Initiative .
Question 7
A drug is 90% plasma protein bound. A patient with hypoalbuminemia is
prescribed this drug. Which of the following is most likely to occur?
A) Decreased free drug concentration
B) Increased free drug concentration and risk of toxicity
C) No change in drug effect
D) Decreased drug half-life
Answer: B
Rationale: In hypoalbuminemia, there are fewer protein binding sites available.
This results in a higher free (unbound) drug concentration, which can increase
pharmacological effects and risk of toxicity. This is particularly important for drugs
that are highly protein bound, such as phenytoin .
Question 8
Which of the following is classified as a Phase I reaction in drug metabolism?
A) Glucuronidation
B) Oxidation via CYP450 enzymes
C) Acetylation
D) Sulfation
Answer: B
Rationale: Phase I reactions (functionalization reactions) include oxidation,
reduction, and hydrolysis, typically mediated by cytochrome P450 enzymes. Phase
